Palatin Technologies
Cedar Brook Corporate Center
4C Cedar Brook Drive
Cranbury
New Jersey
08512
United States
Tel: 609-495-2200
Fax: 609-495-2201
Website: http://www.palatin.com/
403 articles about Palatin Technologies
-
Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
3/8/2012
-
Palatin Technologies to Present at the 24th Annual ROTH OC Growth Stock Conference
3/7/2012
-
Palatin Technologies Reports Second Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be Held on February 15, 2012
2/15/2012
-
Palatin Technologies to Report Fiscal Year 2012 Second Quarter Results; Teleconference and Webcast to be Held on February 15, 2012
2/9/2012
-
Palatin Technologies to Present at 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/9/2012
-
Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
1/17/2012
-
Palatin Technologies Receives $1.1 Million From Sale of New Jersey State Tax Credits
1/17/2012
-
Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference
11/30/2011
-
Palatin Technologies Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
11/15/2011
-
Palatin Technologies to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
11/10/2011
-
Palatin Technologies to Present at 10th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/21/2011
-
Palatin Technologies. Reports Fourth Quarter and Fiscal Year End 2011 Results
9/22/2011
-
Palatin Technologies to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be Held on September 22, 2011
9/19/2011
-
Palatin Technologies to Present at the Rodman & Renshaw Annual Global Investment Conference
9/9/2011
-
Palatin Technologies Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca AB
8/4/2011
-
Palatin Technologies Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6/28/2011
-
Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies
6/23/2011
-
Palatin Technologies Issued U.S. Patent for Key Component in PL-3994 Drug Candidate
6/21/2011
-
Palatin Technologies Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
6/15/2011
-
Palatin Technologies Reports Third Quarter Fiscal Year 2011 Results
5/16/2011